Core needle biopsy

What it is

Core needle biopsy is a procedure that uses a hollow needle to remove a small cylinder of tissue for lab testing, and its key advantage over fine-needle aspiration is that it preserves tissue architecture for histology and often immunohistochemistry. It is also called a core biopsy or Tru-Cut biopsy. Unlike fine-needle aspiration, which mainly collects loose cells, a core needle biopsy removes an actual piece of tissue. That matters because pathologists can often see how cells are arranged within the tissue, which improves diagnosis and can help classify a cancer more accurately.

Core needle biopsy is widely used to investigate suspicious lumps, enlarged lymph nodes, breast lesions, soft-tissue masses, liver or kidney abnormalities, and some bone or head-and-neck lesions. In cancer care, it is often the preferred first biopsy when doctors need enough tissue not only to confirm cancer but also to run additional tests such as receptor studies or immunohistochemistry. In India, this is a routine diagnostic procedure in oncology centres and imaging departments, usually done as an outpatient test under local anaesthesia.

A core needle biopsy may be done by touch for a palpable lump, but many are performed with imaging guidance such as ultrasound, mammography stereotactic guidance, CT, or MRI, depending on where the lesion is and how easily it can be seen.

Biopsy type	What it collects	Main use
Fine-needle aspiration (FNA/FNAC)	Cells and fluid	Quick cytology, cysts, some lymph nodes or thyroid lesions
Core needle biopsy	Small tissue core	Histology, tumour typing, immunohistochemistry
Open surgical biopsy	Larger tissue sample	When needle biopsy is not possible or is inconclusive

How it works

The procedure uses a spring-loaded or vacuum-assisted hollow needle. After the skin is cleaned and numbed with local anaesthetic, the clinician inserts the needle into the abnormal area. The needle cuts and captures a narrow core of tissue, which is then sent to a pathology laboratory.

Several passes are often taken so the lab has enough material. The exact number depends on the organ, lesion size, and whether extra testing is likely. Imaging guidance improves accuracy, especially for small, deep, or non-palpable lesions.

The reason core biopsy is so useful is that it keeps the tissue structure relatively intact. A pathologist can examine not just the appearance of individual cells but also the relationship between cells, stroma, and surrounding tissue. This can help distinguish invasive cancer from in situ disease, identify tumour subtype, and support tests such as estrogen receptor, progesterone receptor, HER2, or other markers when relevant.

In breast cancer, for example, core needle biopsy is commonly preferred over FNA because treatment planning often depends on histology and biomarker testing before surgery or systemic therapy. In head-and-neck and oral lesions, published studies describe Tru-Cut biopsy as a minimally invasive option that can provide more information than cytology alone, though performance varies by site and operator experience.

Evidence and uses

Core needle biopsy is an established diagnostic procedure with broad use across oncology and general medicine. Major clinical references describe it as a standard way to sample suspicious tissue while avoiding a larger surgical procedure in many patients.

Common uses include:

1. Breast lesions: to diagnose benign versus malignant masses and obtain receptor testing.
2. Lymph nodes: to evaluate possible lymphoma, metastasis, infection, or inflammatory disease.
3. Soft-tissue or salivary lesions: when tissue architecture is needed.
4. Liver, kidney, lung, and bone lesions: in selected cases, often with imaging guidance.
5. Masses before cancer treatment: when doctors need a tissue diagnosis before surgery, chemotherapy, or radiation.

Compared with FNA, core needle biopsy usually provides more tissue and more diagnostic detail. Compared with open biopsy, it is less invasive, faster, and usually has a shorter recovery. Studies in breast and maxillofacial settings support its usefulness, especially when immunohistochemistry is needed. At the same time, it is not perfect. A core sample only captures part of a lesion, so sampling error can occur if the needle misses the most informative area.

This is why a benign or non-diagnostic result does not always end the work-up. If the pathology result does not match the scan or clinical suspicion, doctors may recommend a repeat core biopsy, a different imaging-guided approach, or an open surgical biopsy. This principle, often called radiology-pathology concordance, is important in cancer diagnosis.

Safety and interactions

Core needle biopsy is generally safe, but it is still an invasive procedure. The most common short-term effects are mild pain, bruising, and a small amount of bleeding at the biopsy site. Many people can return to normal activities within a day, although the advice varies by organ and by whether sedation was used.

Less common but important risks include:

• Bleeding or haematoma
• Infection
• Pain lasting more than expected
• Injury to nearby structures, depending on the site
• Pneumothorax after some lung or chest-adjacent biopsies
• Non-diagnostic or false-negative sampling

Before the procedure, patients should tell the team about blood thinners, antiplatelet medicines, bleeding disorders, allergies, pregnancy, and prior reactions to anaesthesia. Medicines such as warfarin, heparin, direct oral anticoagulants, aspirin, or clopidogrel may need special instructions from the treating clinician. Do not stop these medicines on your own; the decision depends on why you take them and the bleeding risk of the biopsy site.

After the biopsy, seek urgent care if there is heavy bleeding, fever, increasing redness, worsening swelling, severe pain, shortness of breath, or dizziness. Those symptoms can suggest a complication that needs prompt review.

When to see a clinician

A clinician may recommend core needle biopsy if you have a suspicious lump, an abnormal scan, a persistent enlarged lymph node, or a lesion that needs tissue diagnosis before treatment. It is especially useful when imaging alone cannot reliably tell whether a lesion is benign, inflammatory, infectious, or cancerous.

You should also ask for follow-up if your biopsy result is unclear, labelled inadequate, or does not explain your symptoms or scan findings. In cancer care, the next step after a core biopsy often depends on whether the pathology and imaging agree.

Limitations and open questions

Core needle biopsy is highly useful, but it does not replace every other biopsy method. The sample is limited in size, so some diseases can still be missed, especially if the lesion is heterogeneous or hard to reach. Accuracy depends on the organ involved, the imaging method, the needle type, the number of cores taken, and the experience of the operator and pathologist.

Evidence is strongest for common uses such as breast lesions, but performance varies in oral, salivary, bone, and other less common sites. Some studies in maxillofacial pathology report moderate sensitivity and specificity rather than uniformly high accuracy, which means results must be interpreted in context. A negative core biopsy is reassuring only when it fits the clinical picture and imaging findings.

Open questions remain about the best needle gauge, the ideal number of cores for different organs, and when vacuum-assisted methods are better than standard spring-loaded devices. For patients, the practical point is simple: core needle biopsy is often the best balance between diagnostic yield and invasiveness, but sometimes a repeat or surgical biopsy is still needed to reach a confident diagnosis.